Protalix BioTherapeutics, Inc. (PLX)
NYSEAMERICAN: PLX · Real-Time Price · USD
2.260
-0.070 (-3.00%)
At close: Mar 11, 2025, 4:00 PM
2.214
-0.046 (-2.06%)
After-hours: Mar 11, 2025, 7:50 PM EST
Protalix BioTherapeutics Employees
Protalix BioTherapeutics had 208 employees as of December 31, 2023. The number of employees increased by 11 or 5.58% compared to the previous year.
Employees
208
Change (1Y)
11
Growth (1Y)
5.58%
Revenue / Employee
$219,553
Profits / Employee
-$46,183
Market Cap
166.41M
Employees Chart
PLX News
- 1 day ago - Protalix BioTherapeutics to Announce Fiscal Year 2024 Financial and Business Results on March 17, 2025 - PRNewsWire
- 5 weeks ago - Protalix BioTherapeutics to Participate in the 2025 BIO CEO & Investor Conference - PRNewsWire
- 2 months ago - Protalix BioTherapeutics Issues 2025 Letter to Stockholders - PRNewsWire
- 3 months ago - Chiesi Global Rare Diseases and Protalix BioTherapeutics Announce Validation of Variation Submission by European Medicines Agency for pegunigalsidase alfa - PRNewsWire
- 4 months ago - Protalix BioTherapeutics, Inc. (PLX) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 4 months ago - Protalix BioTherapeutics Reports Third Quarter 2024 Financial and Business Results - PRNewsWire
- 4 months ago - Protalix BioTherapeutics to Announce Third Quarter 2024 Financial and Business Results on November 14, 2024 - PRNewsWire
- 4 months ago - Protalix BioTherapeutics to Present Phase I PRX-115 Data in Late-Breaking Poster at ACR Convergence 2024 - PRNewsWire